| P50 | author | Subho Chakrabarti | Q42664107 |
| P2093 | author name string | Sandeep Grover | |
| | Nidhi Malhotra | |
| | Parmanand Kulhara | |
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| | Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 |
| | Prevalence and correlates of tobacco use in bipolar disorder: data from the first 2000 participants in the Systematic Treatment Enhancement Program. | Q31005227 |
| | Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline | Q31051209 |
| | Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes | Q33682541 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | Serum leptin and cholesterol levels in patients with bipolar disorder | Q44302486 |
| | Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database | Q44608499 |
| | Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients | Q44769160 |
| | Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics | Q44983319 |
| | Burden of general medical conditions among individuals with bipolar disorder | Q45070754 |
| | High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan | Q46133452 |
| | Sedentary behavior, physical activity, and the metabolic syndrome among U.S. adults | Q46440397 |
| | Cardiovascular risk in patients with bipolar disorder | Q46501616 |
| | Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 |
| | Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder | Q46756223 |
| | The prevalence of metabolic syndrome among psychiatric inpatients in Brazil | Q46804628 |
| | Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database | Q46974959 |
| | Weight gain in epileptic patients during treatment with valproic acid: a retrospective study. | Q47303997 |
| | Performance of a weight-related measure of Quality of Life in a psychiatric sample | Q47337805 |
| | Clinical features of bipolar disorder with and without comorbid diabetes mellitus | Q47629610 |
| | Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients | Q48114087 |
| | Obesity and endocrine disorders in women taking valproate for epilepsy. | Q51034614 |
| | Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. | Q51382313 |
| | The prevalence of metabolic syndrome in patients with bipolar disorder. | Q51467623 |
| | C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia. | Q51687988 |
| | Atypical antipsychotics related metabolic syndrome in bipolar patients. | Q51912590 |
| | Sociodemographic characteristics and cardiovascular risk factors in patients with severe mental disorders compared with the general population. | Q51918317 |
| | Prevalence of metabolic syndrome in bipolar disorder: an exploratory study from North India. | Q53142584 |
| | Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study. | Q54767360 |
| | The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania | Q59488864 |
| | Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 |
| | Comment on the provisional report from the WHO consultation | Q62127032 |
| | Cardiovascular risk factors in affective disorder | Q70032439 |
| | Prevalence of diabetes in a manic-depressive population | Q71263887 |
| | Prevalence of overweight and obesity in bipolar patients | Q73805994 |
| | Modal subcomponents of metabolic syndrome in patients with bipolar disorder | Q80605996 |
| | Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness. | Q33889282 |
| | Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 |
| | Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus | Q34137064 |
| | Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation | Q34567335 |
| | Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial | Q34586878 |
| | Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 |
| | Prevalence of metabolic syndrome among Australians with severe mental illness | Q34945943 |
| | The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments | Q34998063 |
| | Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat | Q35006662 |
| | Safety of available agents used to treat bipolar disorder: focus on weight gain | Q35130743 |
| | Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. | Q35631515 |
| | Are mood disorders and obesity related? A review for the mental health professional. | Q35783981 |
| | Physical activity, obesity and cardiovascular diseases | Q36441247 |
| | Associations between bipolar disorder and metabolic syndrome: A review. | Q36556666 |
| | Metabolic syndrome in patients enrolled in a clinical trial of aripiprazole in the maintenance treatment of bipolar I disorder: a post hoc analysis of a randomized, double-blind, placebo-controlled trial | Q36664112 |
| | Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden | Q37207249 |
| | Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder | Q37218782 |
| | Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program. | Q37235620 |
| | Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment | Q37484086 |
| | Weight gain with antidepressants and lithium | Q39535219 |
| | Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder. | Q39789971 |
| | The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation | Q39919146 |
| | Affective disorders, diabetes mellitus and lithium | Q40329492 |
| | Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints | Q42211229 |
| | The rate of metabolic syndrome in euthymic Canadian individuals with bipolar I/II disorder | Q42874068 |
| | Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population | Q42990414 |
| | Effectivity of screening, concepts and attitudes towards metabolic síndrome: a study in bipolar patients followed in Hospital Santa Maria psychiatric consultation | Q43063132 |
| | Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses | Q43093860 |
| | Bipolar disorders and metabolic syndrome: a clinical study in 185 patients | Q43104920 |
| | The role of valproate in metabolic disturbances in bipolar disorder patients | Q43199084 |
| | Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 |
| | Determinants of overweight and obesity in patients with bipolar disorder. | Q43683014 |
| | Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts | Q43689992 |
| | Metabolic syndrome in Italian patients with bipolar disorder | Q43723530 |
| | Insulin-related metabolic changes during treatment with valproate in patients with epilepsy | Q43799181 |
| | Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls | Q43996934 |
| | A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year | Q43999469 |
| | The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype | Q44207549 |
| P433 | issue | 2 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 110-118 | |
| P577 | publication date | 2012-04-01 | |
| P1433 | published in | Indian Journal of Psychological Medicine | Q6020819 |
| P1476 | title | Metabolic syndrome in bipolar disorders | |
| P478 | volume | 34 | |